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Impaired secretion of growth hormone in experimental uremia: Rele-
vance of caloric deficiency. To evaluate the impact of uremia and
associated caloric restriction on physiologically pulsatile growth hormone
(GH) release, we used deconvolution analysis of spontaneous plasma GH
profiles in 5/6-nephrectomized male rats (NX, N = 9). Three different
normal renal function sham-operated groups were used: rats fed a normal
diet ad libitum (SAL, N = 9); NX pair-fed rats (SPF, N = 6); NX rats
pair—fed for protein ingestion but calorically supplemented up to the
energy intake of SAL (SPF+, N = 8). Severe renal failure was confirmed
by much higher (P < 0.001) BUN in NX than sham groups. NX rats were
growth retarded as shown by reduced (P < 0.01) weight and length gains
as compared with sham animals. Deconvolution analysis (mean suM) of
plasma samples obtained every 10 minutes over 6 hours, and 14 to 16 days
after second stage nephrectomy showed that NX rats had a longer GH t½
(17.0 1.8 vs. 11.6 0.8 mm), less GH mass secreted per burst (48 15
vs. 95 16 ng/ml/pulse), lower secretory pulse amplitude (1.9 0.5 vs.
5.8 0.9 ng/ml/min), and a reduced total GFI secretion (240 69 vs.
400 56 nglml/6 hr) than SAL rats. Corresponding data were not
significantly different between NX and SPF, or between SAL and SPF+
groups. In summary, stunted rats with chronic renal failure exhibit a
prolonged GH tY2 and suppression of GH secretory pattern burst mass.
Control data from rats with normal renal function suggest that the
amplitude-specific depression of GH secretion may be attributed, at least
in part, to chronic renal failure-associated calorie deficiency.
Growth retardation is a common manifestation of chronic renal
failure (CRF) in children [1]. Factors such as metabolic acidosis,
renal osteodystrophy, anemia, electrolyte imbalance, hormonal
and nutritional alterations may potentially be involved in its
pathogenesis [2]. However, caloric deficiency, secondary to an-
orexia accompanying the uremic state, and alterations of the
growth hormone (GH)—insulin-like growth factor I (IGF-I) axis
may play an important role in the growth impairment of CRF. A
plausible hypothesis is that caloric malnutrition is particularly
important in the pathogenesis of subnormal growth in infants and
young children with CRF, whereas a disordered GH—IGF-I axis,
which may be influenced not only by uremia per se, but also by
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CRF-associated malnutrition, may be more important in older
children [3, 4].
The status of GH secretion in CRF is controversial. As a result
of the higher circulating concentrations of GH found in patients
with CRF [51, it has been classically believed that pituitary
secretion of GH is stimulated in CRF. However, deconvolution
analysis of plasma GH profiles in CRF children suggests that
elevated plasma levels of GH might be due to a prolonged GH t½,
and correspondingly decreased metabolic clearance rate of the
hormone, rather than enhanced secretion [6]. On the other hand,
Krieg et al [7] have recently reported an increased number of
detectable GH secretory bursts in 5/6-nephrectomized adult rats
with a moderate degree of uremia.
To clarify the influence of uremia and associated malnutrition
on GH secretion in CRF, we applied deconvolution analysis to
evaluate spontaneous plasma GH concentration profiles of
growth-retarded severely-uremic young rats in comparison with
normal renal function rats having either normal nutrition, calorie
malnutrition, or calorie and protein malnutrition.
METHODS
Male Sprague-Dawley rats aged 26 1 days and weighing
65.6 1.1 g were obtained from the breeding area of the animal
facility building of the University of Oviedo. Rats were housed in
individual cages, maintained at an environmental temperature of
22°C and a 12-hour light-dark cycle. They had free access to tap
water.
Study protocol
After a four-day acclimation period, animals underwent either
two-stage 5/6 nephrectomy (NX, N = 9) on days 0 (excision of
approximately two thirds of left kidney) and 7 (removal of right
kidney) or sham operation including renal decapsulation but no
removal of kidney tissue [8]. All animals received standard rat
chow containing 17.2% proteins (A04, Panlab® S. L., Barcelona,
Spain). NX rats were fed ad libitum. After second stage nephrec-
tomy, sham animals were grouped according to diet as follows:
rats fed ad libitum (SAL, N 9); rats given the same amount of
food ingested by the NX group (SPF, N = 6); rats given the mean
amount of food ingested by the NX group and supplemented with
non-protein normocaloric diet (Panlab®) up to a caloric intake
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Table 1. Plasma concentrations of BUN and creatinine and data on growth and nutrient intake in uremic and control rats
SAL(N=9) NX(N=9) SPF(N=6) SPF+(N=8)
BUN mmol/liter 6 0" 46 a 7 1" 3 0"
Creatinine pmol/liter 21.6 1.6" 108.0 75° 17.7 0.0" 17.7 00"
Calorie intake kcal/day 70.9 3.1° 4L6 17" 41.6 1.5" 65.3 0.6°
Protein intake giday 3.9 0.2° 2.3 0.1" 2.3 0.1" 2.3 00"
Protein efficiency g/g
Weight gain g
Length gain cm
1.90 0.07"
73.8 1.9°
5.7 0.2'
0.59 0.11"°
13.6 2.8"
2.4 03"
1.17 0.15""
27.5 4.2" d
4.1 0.1°,"
1.89 0.07"
43.9 18b C
5.1
Abbreviations are: SAL, normal renal function rats fed ad libitum; NX, 5/6-nephrectomized rats; SPF, normal renal function rats pair-fed with the
NX group; SPF+, normal renal function rats receiving the same protein intake as NX animals and calorically supplemented to the energy intake of SAL
rats. Values are given as mean SEM.
a vs. h p < 0.001
vs. d P < 0.01
vs. , P < 0.05
equal to that of SAL group (SPF+, N = 8). The final protein
content of diet ingested by SPF+ rats was 11%.
Body weight was measured with an electronic balance
(OHAUS® GT 2001; OHAUS Europe, Ltd., Cambridge, UK) on
days 0, 7, and daily thereafter until the day of sacrifice. Food
intake was measured daily from day 7 until the day of sacrifice.
Nose to tail tip length was measured with a ruler and a caliper on
days 0, 7, and 17 while rats were under anesthesia. Growth was
assessed by calculating the gains in weight and length from day 7
to day 17. Protein efficiency was calculated as the ratio of grams of
weight gained/grams of protein consumed between days 7 and 17.
On day 17, ten days after second stage nephrectomy, double
catheterization of rats through the right external jugular vein into
the right atrium, and right femoral veins was performed. Cathe-
ters were tunneled subcutaneously to the interscapular space and
extended outside via a protective stainless spring attached to a
roller bearing over the top of the cage in order to allow free
movement of the rat. After four to six days, once the animals had
regained their presurgical weight, serial blood sampling was
performed as follows. Food was removed and catheters were
connected to a peristaltic pump (IPN®; Ismatec Lab, S.A., Zurich,
Switzerland), which provided balanced continuous withdrawal of
blood through the jugular catheter and infusion of warmed (37°C)
resuspended red blood cells through the femoral catheter. Blood
was dispensed in 10 minutes fractions by using a fraction collector
(Gilson FC 203®; Gilson Medical Electronics, Inc., Middleton,
MA, USA) over a six-hour period from 9.00 a.m. to 3.00 p.m.
Each 10-minute sample of blood was immediately centrifuged and
125 j,d of plasma were separated and frozen at —20°C until
analysis. Red cells were resuspended in 125 xl of sterile 0.9%
saline with 20 IU/ml of heparin, added to a reservoir and infused.
All surgical procedures were carried out under intraperitoneal
anesthesia with ketamine chlorhydrate (4 mg/100 g body wt;
Parke-Davis, Barcelona, Spain) and sodium thiopental (1.25
mg/IOU g body wt; B. Braun Medical S.A., Jaen, Spain).
The degree of renal failure was assessed by plasma concentra-
tions of BUN and creatinine, which were measured with a Kodak
Ektachem® analyzer (Eastman Kodak Company, Rochester, NY,
USA).
Rat plasma GH was measured by double-antibody radioimmu-
noassay, as previously described [9j and with reagents kindly
provided by Dr. T. Taylor (National Hormone and Pituitary
Program, National Institute of Diabetes and Digestive and Kidney
Diseases). The standard curve was performed in triplicate by
utilizing rat GH-RP-2 as reference preparation with anti-rat
GH-S-5. Intrassay and interassay variation coefficients were 3 and
9.5%, respectively, for concentrations of 0.075 ng/tube and a
plasma "pool" of 18 ng/ml. The sensitivity of the assay, considered
as 3 SDs above the zero-dose standard, was 4.0 ng/mI.
A multiple-parameter deconvolution method was used to ana-
lyze pulsatile GH secretion and t½ [10, 111. The following
parameters were calculated for each rat: GH secretory pulse
half-duration, amplitude of pulses (maximal secretory rate within
each secretory burst), temporal positions of all secretory pulses,
and the t½ of GH disappearance. The mass of GH secreted per
pulse (pulse area) was calculated as the analytical integral of the
secretory burst resolved by deconvolution. The six-hour endoge-
nous GH production rate (total GH secretion) was calculated as
the product of the mean mass of GH secreted per burst and the
total number of secretory episodes.
For statistical analyses, the normality of data distributions was
determined by the Shapiro-Wilks test and logarithmic transfor-
mation was applied when the data were significantly non-normal.
One-way analysis of variance (ANOVA) and the Student New-
man-Keuls test were used for comparisons among experimental
groups. The results are expressed as mean SEM. A P value
0.05 was considered significant.
RESULTS
Renal function, growth, and food intake data are shown in
Table 1. Plasma concentrations of BUN and creatinine were
markedly higher in the NX rats. Growth impairment of NX rats
was clearly shown by reduced gains in weight and length com-
pared to other groups. Animals of NX, SPF, and SPF+ groups
consumed identical amounts of protein, but significantly less than
SAL rats. SPF+ rats consumed 92.1% of calories ingested by SAL
animals (P = NS). Protein efficiency of NX rats was significantly
lower than that of SPF group and, in turn, both were less than
values observed in SAL and SPF+ animals.
Individual profiles of plasma GH concentrations over time that
are representative of the four groups of rats are shown in Figure
1. In SAL and SPF+ animals, the normal pattern of volleys of GH
secretory bursts recurring with a three to four hour interval was
found. This typical profile was abolished in NX and SPF rats.
As shown in Table 2, deconvolution analysis of six-hour serum
GH profiles revealed a longer GH t½ (17.0 1.8 vs. 11.6 0.8
mm, P < 0.01), depressed total GH secretion over the study
period (240 69 vs. 400 56 ng/ml/6 hr, P < 0.05), lower
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Fig. 1. Representative measured plasma GH concentrations and calculated GH secretory patterns in uremic and control rats. (A, top and B, top)
Observed plasma Gil concentration (points, mean SCM) and best-fit "reconvolved" prediction of plasma GH concentration versus time (continuous
line). A, bottom, and B, bottom) Graphic representation of estimated pituitary GH secretory bursts (pulses), as calculated by deconvolution analysis.
Abbreviations are: SAL, normal renal-function rats fed ad libitum; NX, 5/6-nephrectomized rats; SPF, normal renal-function rats pair-fed with the NX
group; SPF+, normal renal-function rats receiving the same protein intake as NX animals and calorically supplemented up to the energy intake of SAL
rats.
secretory pulse amplitude (1.9 0.5 vs. 5.8 0.9 ng/ml/min, P < not significantly different between SAL and SPF+ groups nor
0.05), and less mass of GH secreted per pulse (48 15 vs. 95 between NX and SPF groups.
16 ng!ml/pulse, P < 0.01) in NX rats compared with SAL. These
differences were also found in the SPF group in comparison with DISCUSSION
SAL except for pulse amplitude, which was not significantly lower Earlier investigations indicate that 5/6 nephrectomy is a useful
(4.0 2.0 vs. 5.8 0.9 ng/ml/min). Measures of GH release were experimental rat model to study growth retardation secondary to
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Table 2. Deconvolution analysis of plasma GH profiles in uremic and control rats
SAL (N=9) NX (N = 9) SPF (N = 6) SPF+ (N=8)
GH t½ mm 11.6 0.8a 17.0 1.8" 17.3 18b 11.2 0.6C
Number of bursts/6 hr 4.6 0.5 5.6 0.6 5.5 0.8 5.4 0.3
Burst half-duration mm 17.1 2.4 24.6 6.6 10.1 2.4 16.3 2.1
Burst area nglmllpulse 95 16C 48 15" C 22 4" 107 26a d
Burst amplitude nglml!mmn 5.8 0.9" 1.9 0.5" 4.0 2.0 7.7 2.5"
Total GH secretion ng/inl/6 hr
Mean plasma GHng/ml
400 56""'
23 3'
240 69"20 3 120 34"13 2" 550 124",30 6C
Abbreviations are: SAL, normal renal function rats fed ad libitum; NX, 5/6-nephrectomized rats; SPF, normal renal function rats pair-fed with the
NX group; SPF+, normal renal function rats receiving the same protein intake as NX animals and calorically supplemented to the energy intake of SAL
rats. Values are given as mean SEM.
'vs. ",P < 0.01
"vs. d P < 0.05
CRF [81, provided an adequate degree of uremia is achieved [12,
13]. In our experiments, the severity of renal failure was confirmed
by plasma creatinine and BUN concentrations 5 and 8 times
higher in NX than SAL rats, respectively. In addition, SPF
animals gained more weight and length than NX rats, indicating
that growth impairment of NX rats was not due solely to
CRF-associated malnutrition. Indeed, caloric supplementation
ameliorated, but did not normalize, the growth rate of SPF+
animals.
Elevated concentrations of GH in single plasma samples [5] and
conflicting inferences concerning overnight and 24-hour total GH
secretion rates [6, 14, 151 have been found in individuals with
CRF. Likewise, abnormal responses to stimuli such as GH
releasing hormone (GHRH), hypoglycemia and thyrotropin re-
leasing hormone [16—il 8] suggest disordered regulation of hypo-
thalamo-pituitary control of OH secretion in CRF. However, the
interpretation of these results is complex because of the physio-
logically pulsatile release of OH, the effect of kidney failure on
renal GH clearance, and the nutritional alterations commonly
associated with CRF. Plasma GH concentrations depend not only
on secretion of the hormone but also on its metabolic clearance
rate. Since 70% of the metabolic clearance of GH takes place in
the kidneys [19] in rats, decreased metabolic clearance and
prolonged GH t½ have been found in CRF [20, 21]. Thus,
techniques such as deconvolution analysis of circulating OH
profiles that correct for unequal hormone t½ in different time
series are particularly relevant in CRF to identify underlying
differences in GH secretory components.
In our study, the t½ of plasma GH in NX rats was 50% longer
than that of SAL animals, which had a OH t½ of 11.6 minutes
similar to that already reported for well-nourished rats with
normal renal function [22, 23]. Total OH secretion was depressed
in the NX group as a result of both reduced OH secretory pulse
amplitude and mass (area) (Table 2). These differences were
specific, since the frequency and duration of GH secretory pulses
were no different in NX and SAL rats. Plasma OH profiles of NX
rats were thus very readily distinguished from the patterns found
in normal male rats [24] and healthy pubertal children [25], which
are characterized by low basal concentrations of GH and high
amplitude pulses. The fact that plasma OH profiles having high
amplitude pulses every three hours and low baseline values have
been shown to induce growth more efficiently than steady elevated
levels or high-frequency pulses of OH [26, 27] suggests that
altered OH dynamics in the NX rats may play a key role as a
pathogenic factor in their subnormal growth.
It should be pointed out that the animals' age and severity of
renal failure and associated malnutrition likely exert marked
influences on the pulsatile mode of OH secretion, since adult rats
with moderate renal failure and fed with a high protein content
diet (30%) have been shown to have normal OH production rates
and higher detectable OH pulse frequency [7].
One can hypothesize that depressed OH secretion in uremic
animals is caused by CRF-induced dysfunction of the neurosecre-
tory control of GH secretion accompanying either alterations of
somatotrope cell function and/or hypothalamic regulation. Lacour
et al [28] have shown decreased pituitary GH content in uremic
rats, and perifusion studies have revealed that the degree of renal
failure has the potential to influence the secretory capacity of the
adenohypophysis. In this respect, the in vitro ability of pituitary
cells to secrete OH in the basal state as well as in the response to
OHRH is preserved in moderate CRF [29], whereas it is impaired
by severe uremia [30]. On the other hand, studies in experimental
uremia have found decreased GHRH gene expression in the
arcuate nucleus [23], normal hypothalamic somatostatin mRNA
[23], and elevated circulating levels of somatostatin [31]. Taken
together, such findings could explain the low amplitude and mass
(decreased area) of GH secretory pulses in NX rats.
The effect of nutrition must be taken into account when the
status of the GH—IGF——I axis is investigated. In humans, analysis
of plasma GH profiles during fasting has revealed increased mean
GH secretion as a result of more frequently detected and higher
amplitude GH pulses [32]. In rats, food restriction causes opposite
effects and GH secretion is markedly reduced because of de-
creased pulse amplitude [33]. In our study, food deprivation
greatly depressed GH secretion in SPF rats. Impairment of OH
secretion was as marked in SPF as NX animals, which could be
related also to stress induced by food withdrawal in SPF rats [34].
In SPF rats, the OH t½ was as long as in NX animals. This finding,
apparently surprising, has also been reported in other studies that
have shown elevated basal OH levels and increased t½ of the
hormone under conditions of food restriction [23, 35]. John and
Gonzalez [36] showed decreased metabolic clearance rate and
lower distribution volume of GH after infusion of OH with several
molecular weights in food-restricted rats. Recently, Challa et al
[37] found a prolonged GH t½ in rats receiving 39% less food
than controls, the degree of prolongation being dependent on the
schedule of food administration. Thus, OH t½ was longer than
that of control animals when food was given in the morning and,
by contrast, was not different from controls when food was
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administered in the evening. Decreased levels of liver GH recep-
tor [38, 39] and/or modifications in binding of circulating GH to its
carrier plasma protein [21] may be responsible for a lower
metabolic clearance rate and secondary prolongation of GH t½ in
situations of restricted intake of food. Calorically supplemented
rats (SPF+ group) showed no significant alteration of plasma GH
profile in comparison with SAL animals. This indicates that
impairment of GH secretion in food restricted rats is largely due
to calorie malnutrition. Okada et al [40] reported that refeeding
after a 72-hour fasting period normalized GH pulse amplitude in
chronically catheterized rats provided a minimum protein intake
was given. As postulated in the uremic rat, the mechanism of
impaired GH secretion in malnourished rats seems to be depen-
dent on reduced production of GHRH and possibly elevated
circulating somatostatin despite normal expression of the soma-
tostatin gene in hypothalamus [41, 42].
In summary, our results indicate that CRF greatly modifies the
normal pattern of physiologically pulsatile GH secretion in rats.
Specific suppression of GH secretory burst mass is the proximate
mechanism in CRF. Impairment of GH secretion in uremic rats
seems to be explicable to a great extent by associated malnutri-
tion, since GH hyposecretion is also present in rats with normal
renal function having similar degrees of calorie and protein
deficiency.
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APPENDIX
Abbreviations are: ANOVA, one-way-analysis of variance; CRF,
chronic renal failure; GH, growth hormone; GHRH, growth hormone
releasing hormone; IGF-I, insulin-like growth factor t; mRNA, messenger
RNA; NX, 5/6 nephrectomized rats; SAL, normal renal-function rats fed
ad libitum; SPF, normal renal function rats pair-fed with the NX group;
SPF+, normal renal-function rats receiving the same protein intake as NX
animals and calorically supplemented to the energy intake of SAL rats.
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